# A Novel Spleen-dedicated Stiffness Measured by FibroScan to Evaluate Cirrhotic Portal Hypertension (CHESS2105)

> **NCT05052892** · — · UNKNOWN · sponsor: **Hepatopancreatobiliary Surgery Institute of Gansu Province** · enrollment: 1000 (estimated)

## Conditions studied

- Portal Hypertension

## Interventions

- **DIAGNOSTIC_TEST:** Hepatic venous pressure gradient

## Key facts

- **NCT ID:** NCT05052892
- **Lead sponsor:** Hepatopancreatobiliary Surgery Institute of Gansu Province
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-09-28
- **Primary completion:** 2025-09-27
- **Final completion:** 2025-09-27
- **Target enrollment:** 1000 (ESTIMATED)
- **Last updated:** 2023-04-25

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05052892

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05052892, "A Novel Spleen-dedicated Stiffness Measured by FibroScan to Evaluate Cirrhotic Portal Hypertension (CHESS2105)". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT05052892. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*